Katalyst Diagnostics offers best in class cutting-edge diagnostic solutions and is helping mental health trusts revolutionise clozapine monitoring through their innovative Point of Care testing analysers. Our portable, plug & play analysers offer finger-prick testing for both Full Blood Count (FBC) and Clozapine-levels from just one drop of blood. This approach minimises patient discomfort and reduces the time and complexity associated with traditional venepuncture methods. Katalyst Diagnostics' technology not only enhances patient compliance but also empowers mental health trusts with rapid and accurate insights, ultimately advancing the effectiveness and efficiency of clozapine treatment.

For over 120 years, Teva has been a different kind of biopharmaceutical company – one that operates across the full spectrum of innovation to continuously better health worldwide.

Teva has a firm commitment to neuroscience, delivering innovation across a number of debilitating diseases. At Teva we want to shine a light on the burden of severe mental illness, and pinpoint strategies which can help to support patients’ overall health (AUST-GB-NP-00052 April 2025).

AGB-Pharma is an independent, Swedish, family-owned, pharmaceutical company dedicated to sleep health, specialising in the treatment of sleep disorders.
Through international expansion of its treatments for sleep disorders, AGB-Pharma hopes to increase awareness of sleep disorders and the effect they have on patients and their families.

MEDICE is a family-owned European pharmaceutical company, renowned for its leadership and innovation in nephrology treatments.

Established in 2022, MEDICE UK supports healthcare professionals and patients across the UK with therapies for conditions such as anaemia in chronic kidney disease.

Our vision is to be a trusted partner within the renal healthcare community, striving for optimised care for patients.

Please visit the MEDICE UK stand E8 to meet our team and to learn more.

We are a leading European pharmaceutical company specialised in the treatment of central nervous system (CNS) disorders, Neuraxpharm is committed to addressing the unmet needs of patients with psychiatric and neurological conditions.

Our purpose is to offer a comprehensive and specialised range of CNS therapeutic solutions to improve the daily lives of patients across Europe and beyond.

For doctors, pharmacists, caretakers, patients and their families, we are your expert CNS specialist.

Colonis Pharma is an innovative company with great ambition to develop value-added medicines and treatment options that empower patients’ lives. We’re experts in repurposing medicines, transforming existing molecules and optimising existing therapies. Our rigorous development process enables us to extend the life cycle of medicines and tailor them to address unmet clinical needs.

The purpose of Idorsia is to challenge accepted medical paradigms, answering the questions that matter most.

LearnItOnline creates evidence-based, CPD-accredited education for healthcare professionals, with a particular focus on mental health, medicines and physical healthcare. Our engaging online courses combine trusted clinical guidance with practical learning that can be applied in everyday practice.

Organisations can choose from ready-made programmes, tailored content or bespoke learning solutions, delivered through their own learning management system or our online platform. We also develop clear, accessible resources for patients and carers, helping people feel informed and supported.

Through collaboration with healthcare experts, professional bodies and people with lived experience, we aim to transform the way healthcare education is delivered.

Luye Pharma UK is a growing, UK-based company with a predominant focus on the disease
areas of the central nervous system (CNS). We are committed to supplying innovative, high-
quality and affordable medicines to the NHS, working hand-in-hand making small changes that
can make a big difference to the lives of patients and those around them.

Viatris is a different kind of healthcare company, with a mission to empower people to live healthier at every stage of life, regardless of geography or circumstance. We do this via Access, Leadership and Partnership.

Aston University’s Mental Health Pharmacy team delivers specialist postgraduate education for pharmacy professionals working across mental health services. Our programmes include the PG Certificate in Mental Health Therapeutics, PG Diploma in Mental Health Pharmacy, and MSc in Psychiatric Pharmacy Practice, enabling practitioners to gain recognised postgraduate qualifications while developing advanced knowledge, critical appraisal skills and confidence in the pharmacological management of mental illness.
With over 25 years of experience in postgraduate mental health pharmacy education, our programmes combine contemporary evidence-based practice with clinically relevant application, supporting learners to enhance their practice and progress their professional development. Our commitment to an excellent student experience is reflected in our recent 95.7% overall satisfaction rating in the Postgraduate Taught Experience Survey (PTES). We are also looking forward to enrolling students on a new Mental Health Clinically Enhanced Independent Prescribing module, designed to support pharmacists developing advanced clinical roles within mental health services.
Members of the Aston team will be available throughout the conference to discuss our programmes, answer questions about entry requirements and study options, and explore how our courses can support the development of the mental health pharmacy workforce.

The NHS Specialist Pharmacy Service (SPS) supports the safe, effective and efficient use of medicines across the NHS by providing expert guidance, quality assured resources, and specialist operational support. We connect national medicines expertise with local healthcare teams to ensure consistent, high quality practice and promote safer, optimised use of medicines. Through our “Do Once and Share” approach, we deliver direct benefits to patients and teams across the NHS, reducing duplication and strengthening system-wide medicines practice.
Visit our stand to meet our team and explore how our written guidance, medicine tools and webinars support you in practice.